Long-Lasting Cognitive Abnormalities after COVID-19

Considering the mechanisms capable of causing brain alterations in COVID-19, we aimed to study the occurrence of cognitive abnormalities in the months following hospital discharge. We recruited 38 (aged 22–74 years; 27 males) patients hospitalized for complications of SARS-CoV-2 infection in nonintensive COVID units. Participants underwent neuropsychological testing about 5 months after hospital discharge. Of all patients, 42.1% had processing speed deficits, while 26.3% showed delayed verbal recall deficits. Twenty-one percent presented with deficits in both processing speed and verbal memory. Bivariate analysis revealed a positive correlation between the lowest arterial oxygen partial pressure (PaO2) to fractional inspired oxygen (FiO2) (P/F) ratio during hospitalization and verbal memory consolidation performance (SRT-LTS score, r = 0.404, p = 0.027), as well as a positive correlation between SpO2 levels upon hospital arrival and delayed verbal recall performance (SRT-D score, rs = 0.373, p = 0.042). Acute respiratory distress syndrome (ARDS) during hospitalization was associated with worse verbal memory performance (ARDS vs. no ARDS: SRT-LTS mean score = 30.63 ± 13.33 vs. 44.50 ± 13.16, p = 0.007; SRT-D mean score = 5.95 ± 2.56 vs. 8.10 ± 2.62, p = 0.029). Cognitive abnormalities can frequently be found in COVID-19 patients 5 months after hospital discharge. Increased fatigability, deficits of concentration and memory, and overall decreased cognitive speed months after hospital discharge can interfere with work and daily activities.

[1]  F. Biglioli,et al.  The Many Faces of Covid-19 at a Glance: A University Hospital Multidisciplinary Account From Milan, Italy , 2021, Frontiers in Public Health.

[2]  T. Hobman,et al.  Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19 , 2020, Viruses.

[3]  A. Priori,et al.  Psychological Impact During the First Outbreak of COVID-19 in Italy , 2020, Frontiers in Psychiatry.

[4]  A. Ruiz,et al.  Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia , 2020, Frontiers in Aging Neuroscience.

[5]  Seyed A Safavynia,et al.  The ‘third wave’: impending cognitive and functional decline in COVID-19 survivors , 2020, British Journal of Anaesthesia.

[6]  Hailin Zhao,et al.  Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications , 2020, Inflammation.

[7]  I. Koralnik,et al.  Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients , 2020, Annals of clinical and translational neurology.

[8]  M. Aepfelbacher,et al.  Neuropathology of patients with COVID-19 in Germany: a post-mortem case series , 2020, The Lancet Neurology.

[9]  A. Egbert,et al.  Brain abnormalities in COVID-19 acute/subacute phase: A rapid systematic review , 2020, Brain, Behavior, and Immunity.

[10]  G. Tosato,et al.  Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection , 2020, Cells.

[11]  Shaojia Lu,et al.  The landscape of cognitive function in recovered COVID-19 patients , 2020, Journal of Psychiatric Research.

[12]  S. Farhadian,et al.  Neuroinvasion of SARS-CoV-2 in human and mouse brain , 2020, bioRxiv.

[13]  A. Pisani,et al.  The international European Academy of Neurology survey on neurological symptoms in patients with COVID‐19 infection , 2020, European journal of neurology.

[14]  M. Heneka,et al.  Immediate and long-term consequences of COVID-19 infections for the development of neurological disease , 2020, Alzheimer's Research & Therapy.

[15]  A. Priori,et al.  An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID) , 2020, Neurological Sciences.

[16]  Paolo Fusar-Poli,et al.  Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic , 2020, The Lancet Psychiatry.

[17]  A. Priori,et al.  First ultrastructural autoptic findings of SARS-Cov-2 in olfactory pathways and brainstem. , 2020, Minerva anestesiologica.

[18]  Thomas J Oxley,et al.  Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young , 2020, The New England journal of medicine.

[19]  J. McArthur,et al.  Neurological manifestations associated with COVID-19: a review and a call for action , 2020, Journal of Neurology.

[20]  Holger Moch,et al.  Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.

[21]  S. Kremer,et al.  Neurologic Features in Severe SARS-CoV-2 Infection , 2020, The New England journal of medicine.

[22]  D. Gommers,et al.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19 , 2020, Thrombosis Research.

[23]  L. Mao,et al.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. , 2020, JAMA neurology.

[24]  K. Hashimoto,et al.  Nervous system involvement after infection with COVID-19 and other coronaviruses , 2020, Brain, Behavior, and Immunity.

[25]  Guillermo J. Lagos-Grisales,et al.  Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis , 2020, Travel Medicine and Infectious Disease.

[26]  J. Molinuevo,et al.  White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants , 2019, Human brain mapping.

[27]  E. Ely,et al.  Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms , 2019, Critical Care.

[28]  Jun Chen,et al.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke , 2017, Circulation research.

[29]  T. Rice,et al.  Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers , 2016, Intensive Care Medicine.

[30]  R. Pedone,et al.  Normative data for the Montreal Cognitive Assessment in an Italian population sample , 2015, Neurological Sciences.

[31]  U. Demkow,et al.  Cross-talk between the inflammatory response, sympathetic activation and pulmonary infection in the ischemic stroke , 2014, Journal of Neuroinflammation.

[32]  David T. Huang,et al.  The Adult Respiratory Distress Syndrome Cognitive Outcomes Study: long-term neuropsychological function in survivors of acute lung injury , 2013, Critical Care.

[33]  A. Lundervold,et al.  Subthreshold Depressive Symptoms have a Negative Impact on Cognitive Functioning in Middle-Aged and Older Males , 2013, Front. Psychol..

[34]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[35]  S. Sorbi,et al.  The Rao’s Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population , 2006, Multiple sclerosis.

[36]  R. Hopkins,et al.  Brain atrophy and cognitive impairment in survivors of acute respiratory distress syndrome , 2006, Brain injury.

[37]  B. Sellhaus,et al.  S-100 Protein and Neurohistopathologic Changes in a Porcine Model of Acute Lung Injury , 2005, Anesthesiology.

[38]  B. Berk,et al.  Angiotensin II and the Endothelium: Diverse Signals and Effects , 2005, Hypertension.

[39]  G. Navis,et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.

[40]  E. Bigler,et al.  Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. , 1999, American journal of respiratory and critical care medicine.

[41]  L. Squire,et al.  The medial temporal lobe memory system , 1991, Science.

[42]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[43]  S. Sekaran,et al.  Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system. , 2018, Acta virologica.

[44]  M. Bhide,et al.  How viruses infiltrate the central nervous system. , 2017, Acta virologica.

[45]  J. Cervós-Navarro,et al.  Brain changes in experimental chronic hypoxia. , 1991, Experimental pathology.